Publication details
Studie VERTIS‑CV
| Title in English | VERTIS-CV study |
|---|---|
| Authors | |
| Year of publication | 2021 |
| Type | Article in Periodical |
| Magazine / Source | Remedia |
| MU Faculty or unit | |
| Citation | |
| web | http://www.remedia.cz/Archiv-rocniku/Rocnik-2021/2-2021/e-33h-37m.magissue.aspx?Page=2 |
| Keywords | VERTIS-CV |
| Description | The VERTIS-CV study tested the efficacy of the sodium-glucose cotransporter 2 (SGLT2i) inhibitor ertugliflozin, which is indicated as an oral antidiabetic agent. |